Zulresso

Active Ingredient(s): Brexanolone
FDA Approved: * March 19, 2019
Pharm Company: * SAGE THERAPEUTICS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Zulresso Overview

Allopregnanolone is a naturally occurring neurosteroid which is made in the body from the hormone progesterone.[9][10] As a medication, allopregnanolone is referred to as brexanolone, sold under the brand name Zulresso,[6][11] and used to treat postpartum depression.[10][12][13] It is used by injection into a vein over a 60-hour period under medical supervision.[10]&...

Read more Zulresso Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Allopregnanolone

Recent Zulresso Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Brexanolone
  • Injection: 5mg/ml
  • Solution: 100mg/20ml (5mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zulresso: (1 result)

Sorted by National Drug Code
  • 72152-547 Zulresso 5 mg/ml Intravenous Injection, Solution by Sage Therapeutics, Inc.

Other drugs which contain Brexanolone or a similar ingredient: (1 result)